Hematology / Oncology / Cancer Center / Breast Clinic

Research Output

Filter
Comment/debate
2019
2018

Best Practices for Physician-Scientist Training Programs: Recommendations from the Alliance for Academic Internal Medicine

Blanchard, M., Burton, M. C., Geraci, M. W., Madaio, M. P., Marsh, J. D., Proweller, A., Rockey, D. C., Salata, R. A., Tan, W., Williams, C. S., Zaidi, M. & Todd, R. F., May 1 2018, In : American Journal of Medicine. 131, 5, p. 578-584 7 p.

Research output: Contribution to journalComment/debate

5 Scopus citations

Correction: Baseline tumor size is an research independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab(Clin Cancer Res (2018)24(4960–7)DOI: 10.1158/1078-0432.CCR-17-2386)

Joseph, R. W., Elassaiss-Schaap, J., Kefford, R., Hwu, W. J., Wolchok, J. D., Joshua, A. M., Ribas, A., Stephen Hodi, F., Hamid, O., Robert, C., Daud, A., Dronca, R. S., Hersey, P., Weber, J. S., Patnaik, A., de Alwis, D. P., Perrone, A., Zhang, J., Peter Kang, S., Ebbinghaus, S. & 2 others, Anderson, K. M. & Gangadhar, T. C., Dec 1 2018, In : Clinical Cancer Research. 24, 23, 1 p.

Research output: Contribution to journalComment/debate

8 Scopus citations

Corrigendum: N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: A North Central Cancer Treatment Group (NCCTG) Trial (Ann Oncol (2010) 21 (493–497) DOI: 10.1093/annonc/mdp328)

Tan, W. W., Hillman, D. W., Salim, M., Northfelt, D. W., Anderson, D. M., Stella, P. J., Niedringhaus, R., Bernath, A. M., Gamini, S. S., Palmieri, F. & Perez, E. A., Jan 1 2018, In : Annals of Oncology. 29, 10, p. 493-497 5 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2017

Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (Breast Cancer Research and Treatment, (2017), 165, 2, (329-341), 10.1007/s10549-017-4304-7)

Cortés, J., Rugo, H. S., Awada, A., Twelves, C., Perez, E. A., Im, SA. A., Gómez-Pardo, P., Schwartzberg, L. S., Diéras, V., Yardley, D. A., Potter, D. A., Mailliez, A., Moreno-Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L. & O’Shaughnessy, J., Nov 1 2017, In : Breast Cancer Research and Treatment. 166, 1, p. 327-328 2 p.

Research output: Contribution to journalComment/debate

2014

Commentary

Perez, E. A., Serene, M. & Durling, F. C., Jul 2014, In : Clinical Advances in Hematology and Oncology. 12, 7, 1 p.

Research output: Contribution to journalComment/debate

Editorial comment

Tan, W. W., Jan 1 2014, In : Urology. 83, 1, 1 p.

Research output: Contribution to journalComment/debate

Erratum: Dual HER2 blockade: Preclinical and clinical data [Breast Cancer Research, (2014)]. DOI: 10.1186/s13058-014-0419-5

Patel, T. A., Dave, B., Rodriguez, A. A., Chang, J. C., Perez, E. A. & Colon-Otero, G., Nov 6 2014, In : Breast Cancer Research. 16, 1, 468.

Research output: Contribution to journalComment/debate

Erratum: Breast cancer mortality among American Indian and Alaska Native women, 1990-2009 (Am J Public Health (2014) 104 (S432-S438) DOI: 10.2105/AJPH.2013.301720)

White, A., Richardson, L. C., Li, C., Ekwueme, D. U. & Kaur, J. S., Aug 2014, In : American journal of public health. 104, 8, p. e6

Research output: Contribution to journalComment/debate

4 Scopus citations

Erratum: Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma (Cancer DOI: 10.1002/cncr.28521)

Joseph, R. W., Kapur, P., Serie, D. J., Eckel-Passow, J. E., Parasramka, M., Ho, T., Cheville, J. C., Frenkel, E., Rakheja, D., Brugarolas, J. & Parker, A., Jun 1 2014, In : Cancer. 120, 11, p. 1752-1753 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2013

Reply

Tan, W., Jan 1 2013, In : Urology. 81, 1, 1 p.

Research output: Contribution to journalComment/debate

2012

Choosing the best trastuzumab- based adjuvant chemotherapy regimen: Should we abandon anthracyclines?

Burstein, H. J., Piccart-Gebhart, M. J., Perez, E. A., Hortobagyi, G. N., Wolmark, N., Albain, K. S., Norton, L., Winer, E. P. & Hudis, C. A., Jun 20 2012, In : Journal of Clinical Oncology. 30, 18, p. 2179-2182 4 p.

Research output: Contribution to journalComment/debate

33 Scopus citations

Erratum: RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer (Gynecologic Oncology (2012) 124 (589-597))

Vishnu, P., Colon-Otero, G., Kennedy, G. T., Marlow, L. A., Kennedy, W. P., Wu, K. J., Santoso, J. T. & Copland, J. A., Dec 1 2012, In : Gynecologic oncology. 127, 3, 1 p.

Research output: Contribution to journalComment/debate

Multiple myeloma and immunomodulation: Regulating the regulatory cells

Kasyapa, C. S., Sher, T. & Chanan-Khan, A. A., Jul 1 2012, In : Leukemia and Lymphoma. 53, 7, p. 1253-1254 2 p.

Research output: Contribution to journalComment/debate

5 Scopus citations

Progress against solid tumors in danger: The metastatic breast cancer example

Corteś, J., Calvo, E., González-Martín, A., Dawood, S., Llombart-Cussac, A., De Mattos-Arruda, L., Gómez, P., Silva, O., Perez, E. A., Rugo, H. S., Lluch, A. & Hortobagyi, G. N., Oct 1 2012, In : Journal of Clinical Oncology. 30, 28, p. 3444-3447 4 p.

Research output: Contribution to journalComment/debate

18 Scopus citations
2010

Chemotherapy induced amenorrhea as an indicator of better survival in early breast cancer

Swain, S. M., Jeong, J. H., Geyer, C. E., Costantino, J. P., Pajon, E. R., Fehrenbacher, L., Atkins, J. N., Polikoff, J., Vogel, V. G., Erban, J. K., Rastogi, P., Livingston, R. B., Perez, E. A., Mamounas, E. P., Land, S. R., Ganz, P. A., Wolmark, N. & Gluz, O., Oct 1 2010, In : Breast Care. 5, 5, p. 365-366 2 p.

Research output: Contribution to journalComment/debate

Editorial Comment

Tan, W. W., May 1 2010, In : Urology. 75, 5, 1 p.

Research output: Contribution to journalComment/debate

Erratum: Changes to adjuvant systemic therapy in breast cancer: A decade in review (Clinical Breast Cancer (2010) 10:3 (196-208) DOI: 10.3816/CBC.2010.n. 027)

Saurel, C. A., Patel, T. A. & Perez, E. A., Oct 1 2010, In : Clinical breast cancer. 10, 5, 1 p.

Research output: Contribution to journalComment/debate

Hepatitis C in the rituximab era

Foran, J. M., Dec 9 2010, In : Blood. 116, 24, p. 5081-5082 2 p.

Research output: Contribution to journalComment/debate

9 Scopus citations

Hyperphosphatemia in a 56-year-old man with hypochondrial pain: Commentary

Roy, V., Jun 1 2010, In : Clinical chemistry. 56, 6, p. 895-896 2 p.

Research output: Contribution to journalComment/debate

The impact of multimodal therapy on survival for uterine carcinosarcomas

Bosquet, J. G., Terstriep, S. A., Cliby, W. A., Brown-Jones, M., Kaur, J. S., Podratz, K. C. & Keeney, G. L., May 1 2010, In : Obstetrical and Gynecological Survey. 65, 5, p. 313-314 2 p.

Research output: Contribution to journalComment/debate

2009

The many lives of thalidomide

Patel, M. P. & Chanan-Khan, A. A., Aug 17 2009, In : Leukemia and Lymphoma. 50, 6, p. 861-862 2 p.

Research output: Contribution to journalComment/debate

2008

Disparities in participation in cancer clinical trials in the United States: A symptom of a healthcare system in crisis

Colon-Otero, G., Smallridge, R. C., Solberg, L. A., Keith, T. D., Woodward, T. A., Willis, F. B. & Dunn, A. N., Feb 1 2008, In : Cancer. 112, 3, p. 447-454 8 p.

Research output: Contribution to journalComment/debate

32 Scopus citations
2006
2004

Increasing access to clinical cancer trials and emerging technologies for minority populations: The Native American project

Petereit, D. G., Rogers, D., Govern, F., Coleman, N., Osburn, C. H., Howard, S. P., Kaur, J., Burhansstipanov, L., Fowler, C. J. F., Chappell, R. & Mehta, M. P., Dec 1 2004, In : Journal of Clinical Oncology. 22, 22, p. 4452-4455 4 p.

Research output: Contribution to journalComment/debate

32 Scopus citations